Drug Profile
Risperidone sustained-release - DURECT Corporation/Indivior
Alternative Names: Long-acting Risperidone - Indivior; PERSERIS; RBP 7000Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Reckitt Benckiser Pharmaceuticals
- Developer HLS Therapeutics; Indivior
- Class Antidepressants; Antineoplastics; Antipsychotics; Behavioural disorder therapies; Fluorinated hydrocarbons; Isoxazoles; Mood stabilisers; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Schizophrenia